PRAX Q2 2024 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$357,000-54.3% YoY

Gross Profit

-$27M-7535.9% margin

Operating Income

-$37M-10500.8% margin

Net Income

-$33M-9153.2% margin

EPS (Diluted)

$-1.74

QoQ Revenue Growth

-17.2%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$27M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$441M

Total Liabilities

$22M

Stockholders' Equity

$419M

Cash & Equivalents

$145M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$357,000	$781,000	-54.3%
Gross Profit	-$27M	-$25M	-8.3%
Operating Income	-$37M	-$35M	-7.2%
Net Income	-$33M	-$34M	+4.8%

Revenue Segments

License

$400,000100%